Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
A molded article such as a tablet is provided for administration to an oral cavity of a subject to treat or prevent a cyclooxygenase-2 mediated condition, disorder or disease. The molded article comprises a moldable blend of a therapeutically effective amount of a selective cyclooxygenase-2 inhibito...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
04.03.2002
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A molded article such as a tablet is provided for administration to an oral cavity of a subject to treat or prevent a cyclooxygenase-2 mediated condition, disorder or disease. The molded article comprises a moldable blend of a therapeutically effective amount of a selective cyclooxygenase-2 inhibitory drug with a pharmaceutically acceptable excipient carrier system consisting predominantly of one or more carbohydrates, wherein ingredients and amounts thereof in the molded article and a process for preparing the molded article are selected such that the molded article exhibits rapid disintegration in the oral cavity, and wherein the moldable blend is prepared by a process step not requiring wet granulation. |
---|---|
AbstractList | A molded article such as a tablet is provided for administration to an oral cavity of a subject to treat or prevent a cyclooxygenase-2 mediated condition, disorder or disease. The molded article comprises a moldable blend of a therapeutically effective amount of a selective cyclooxygenase-2 inhibitory drug with a pharmaceutically acceptable excipient carrier system consisting predominantly of one or more carbohydrates, wherein ingredients and amounts thereof in the molded article and a process for preparing the molded article are selected such that the molded article exhibits rapid disintegration in the oral cavity, and wherein the moldable blend is prepared by a process step not requiring wet granulation. |
Author | MARK J KONTNY TUGRUL T KARARLI TRANG T. LE |
Author_xml | – fullname: MARK J KONTNY – fullname: TUGRUL T KARARLI – fullname: TRANG T. LE |
BookMark | eNqFyrsKAjEQQNEUWvj6BucHFjbKgu0iPmrRehmzs3EgzixJBPP3WthbXTjcuZmICs3M6YIj96FAz4klk4-YWTxoxACDxucrfEEFdAAEV1xQfRdPgomqDbA8-M5Z49JMBwyJVr8uzPp4uO7PFY3aURrRkVDu2tuuqa2tbbv9f3wA-Pg1Sw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | AU8501101A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU8501101A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:00:12 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU8501101A3 |
Notes | Application Number: AU19850001101 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020304&DB=EPODOC&CC=AU&NR=8501101A |
ParticipantIDs | epo_espacenet_AU8501101A |
PublicationCentury | 2000 |
PublicationDate | 20020304 |
PublicationDateYYYYMMDD | 2002-03-04 |
PublicationDate_xml | – month: 03 year: 2002 text: 20020304 day: 04 |
PublicationDecade | 2000 |
PublicationYear | 2002 |
RelatedCompanies | PHARMACIA CORPORATION |
RelatedCompanies_xml | – name: PHARMACIA CORPORATION |
Score | 2.5481021 |
Snippet | A molded article such as a tablet is provided for administration to an oral cavity of a subject to treat or prevent a cyclooxygenase-2 mediated condition,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020304&DB=EPODOC&locale=&CC=AU&NR=8501101A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFPVNp7L5mQfpW1H73YciWz8cwj4Ym-xtNF3KCqMta0X733sJrfqyt5BAuIT88rvL5e4AHo1YtUxUg_HwWpqsIaPIVLENWdWpEuuGZTBROmE0NoYL7X2pL1uwaWJhRJ7QL5EcEREVId5LcV_nf49YnvhbWTzRBLuy12DueFJjHSvc0yd5A8efTryJK7kuWpLSeOZYOie6l_4BHKISbXIs-B8DHpOS_yeU4AyOpjhXWp5Di6UdOHGbumsdOB7V7m5s1sgrLuBtFubJeluRdVI0KR6QdQgPsCdc8azLcJEsJiGJqmibZd8Vng5kKVkhSbpJKIJ3dwkPgT93hzJKtPpd_Kq_aERXr6CdZinrAqG2aVPdiNDYUbVnZtvMUjUk2ygOdTNS4h50981yvX_oBk5FrRP-w0q7hXa5-2R3SLklvRe79QMNfIXf |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUQN-0Qezt0Xd9x6IgW2IygYhw_C2rGMLS8i2wIzy33ttmPrCW9MmzbXpr7-7Xu8O4F5LZENHNRgPr6GICjKKSCVTE2WVSomqGVrMSye4njacKW9zdV6DZRULw_OEfvHkiIioCPFe8vu6-HvEsvnfys0DTbErfx74XVuorGOJefoEu991JmN7bAmWhZak4E27hsqI7ql3AIeoYOsMC85Hn8WkFP8JZXAKRxOcKyvPoBZnTWhYVd21Jhy7O3c3NnfI25zDyzQs0sVqSxbppkrxgKxDWIA9YYrnrgwXyRMSkmgbrfL8e4unA1lKlEiaLVOK4F1fQGfg-NZQRImC38UHvVklunwJ9SzP4hYQauomVbUIjR1ZeYxNMzZkBck2SkJVj6SkDa19s1ztH-pAY-i7o2D06r1fwwmve8J-Wyk3UC_Xn_Et0m9J7_jO_QCAsojS |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Rapidly+disintegrating+oral+formulation+of+a+cyclooxygenase-2+inhibitor&rft.inventor=MARK+J+KONTNY&rft.inventor=TUGRUL+T+KARARLI&rft.inventor=TRANG+T.+LE&rft.date=2002-03-04&rft.externalDBID=A&rft.externalDocID=AU8501101A |